← ANALYSTS · TIPRANKS

Dennis Ding · Jefferies

#2230among 12,504 TipRanks analysts★★★★★★★★★★
Hits 58% 48 of 83 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +12.3% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 8 / 2 / 0
Upside of the analyst’s targets +146.3% Average over 10 current targets, to the last price
The market’s answer to the ratings +0.1% Day-0 move against SPY in the rating’s direction, average over 5 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 8on TipRanks 12:45 PCRXIWMPacira Pharmaceuticals · $1.4B Downgrade Hold $36.00 −0.9% +44.8%next day −0.8% · 5 days +0.1%
Sep 8on TipRanks 13:55 TARSIWMTarsus Pharmaceuticals · $3.5B Reiterated Buy $105 +54.3% −3.4%next day −4.6% · 5 days −9.2%
Sep 8on TipRanks 11:05 ROIVRoivant Sciences · $25.0B Reiterated Buy $42.00 → $52.00+23.8% +55.1% +19.3%next day +1.3% · 5 days −3.7%
Jul 13on TipRanks 05:40 KARDIWMKardigan, Inc. · $1.3B Initiated Buy $40.00 +207.0% −3.7%next day −5.8% · 5 days −8.1%
Jun 26on TipRanks 15:25 ARDXIWMArdelyx · $795M Reiterated Buy $15.00 +385.4% −7.7%next day −7.4% · 5 days −6.8%
Jun 15on TipRanks 10:15 RYTMIWMRhythm Pharmaceuticals · $6.0B Reiterated Buy $125 +45.1% −0.3%next day +0.6% · 5 days +20.9%
May 19on TipRanks 09:35 SGPIWMSpyGlass Pharma · $827M Reiterated Buy $62.00 +158.3% −4.0%next day +2.2% · 5 days −7.1%
Apr 21on TipRanks Apr 20 16:35 AMPHIWMAmphastar Pharmaceuticals · $1.1B Downgrade Hold $30.00 → $22.00−26.7% −15.0% −6.8%next day −2.0% · 5 days +1.8%
Mar 19on TipRanks 05:25 OLMAIWMOlema Pharmaceuticals · $601M Initiated Buy $43.00 → $40.00−7.0% +507.9% +3.0%next day −4.4% · 5 days −3.7%
Dec 11on TipRanks Feb 2 14:55 ABUSIWMArbutus Biopharma · $850M Reiterated Buy $7.00 +65.9% +1.5%next day +1.9% · 5 days −0.9%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗